These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 9231053

  • 1. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL, Stirling HF, Kelnar CJ, Savage MO, Dunger DB, Buckler JM, Shalet SM.
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [Abstract] [Full Text] [Related]

  • 2. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
    Neyzi O, Yordam N, Ocal G, Bundak R, Darendeliler F, Açikgöz E, Berberoğlu M, Günöz H, Saka N, Calikoğlu AS.
    Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency.
    Chen RG, Shen YN, Yei J, Wang CF, Xie DH, Wang XH, Zhou JD, Chen CY, Wu YL, Gunnarsson R.
    Acta Paediatr Suppl; 1993 Mar; 388():32-5; discussion 36. PubMed ID: 8329830
    [Abstract] [Full Text] [Related]

  • 4. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.
    Kirk JM, Trainer PJ, Majrowski WH, Murphy J, Savage MO, Besser GM.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):487-93. PubMed ID: 7955460
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone (GH) profiles in response to continuous subcutaneous infusion of GH-releasing hormone(1-29)-NH2 in children with GH deficiency.
    Tauber MT, Pienkowski C, Pigeon P, Cataldi M, Rochiccioli P.
    Acta Paediatr Suppl; 1993 Mar; 388():28-30; discussion 31. PubMed ID: 8329829
    [Abstract] [Full Text] [Related]

  • 6. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.
    Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, Landy H, Eengrand P, Shah S.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1189-96. PubMed ID: 8772599
    [Abstract] [Full Text] [Related]

  • 7. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
    Sulmont V, Brauner R, Fontoura M, Rappaport R.
    Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
    [Abstract] [Full Text] [Related]

  • 8. Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth.
    Hümmelink R, Sippell WG, Benoit KG, Danielson K, Faijerson Y.
    Acta Paediatr Suppl; 1993 Mar; 388():23-6; discussion 27. PubMed ID: 8329828
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy.
    Duck SC, Schwarz HP, Costin G, Rapaport R, Arslanian S, Hayek A, Connors M, Jaramillo J.
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880
    [Abstract] [Full Text] [Related]

  • 12. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ, Rodda C, Tsagarakis S, Davies PS, Grossman A, Rees LH, Preece MA, Savage MO, Besser GM.
    Lancet; 1987 Jan 03; 1(8523):5-8. PubMed ID: 2879138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Growth hormone state after completion of treatment with growth hormone.
    Clayton PE, Price DA, Shalet SM.
    Arch Dis Child; 1987 Mar 03; 62(3):222-6. PubMed ID: 3566314
    [Abstract] [Full Text] [Related]

  • 15. Growth response to growth hormone therapy following craniospinal irradiation.
    Clayton PE, Shalet SM, Price DA.
    Eur J Pediatr; 1988 Aug 03; 147(6):597-601. PubMed ID: 3181200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P.
    J Endocrinol Invest; 1990 Apr 03; 13(4):307-16. PubMed ID: 2115060
    [Abstract] [Full Text] [Related]

  • 18. Growth response to growth hormone therapy following cranial irradiation.
    Clayton PE, Shalet SM, Price DA.
    Eur J Pediatr; 1988 Aug 03; 147(6):593-6. PubMed ID: 3181199
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR.
    J Clin Endocrinol Metab; 1986 Jul 03; 63(1):174-9. PubMed ID: 3086356
    [Abstract] [Full Text] [Related]

  • 20. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F, Lanes R, Pugliese M, Fort P, Perez I, Puentes S, Cervantes C, Gunczler P, Chasalow FI, Recker B.
    J Clin Endocrinol Metab; 1992 Nov 03; 75(5):1255-60. PubMed ID: 1430086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.